Lihat Juga

• Peran aktivasi reseptor insulin-like growth factor 1 (IGF1R) akibat hipoksia pada proses epithelialmesenchymal transition sel kanker paru = Role of insulin-like growth factor 1 receptor activation under hypoxia in epithelial- mesenchymal transition of lung cancer
  oleh: Raden Fariz Nurwidya
  Terbitan: (2016)
• Epidermal Growth Factor Receptor (EGFR) sebagai Sasaran Terapi Kanker Kolorektal (Epidermal Growth Factor Receptor (EGFR) as Therapeutic Target in Colorectal Cancer)
  Terbitan: (2009)
• Profil Efikasi dan Toksisitas Terapi Target Baru Golongan Epidermal Factor Receptor-Tyrosine Kinase Inhibitor (EGFRTKi)Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil Non Skuamosa Dengan Mutasi EGFR Positif Dibandingkan Dengan Kemoradioterapi Pada EGFR Wild Type = Profile of Efficacy and Toxicity The New Targeted Therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in Non Small Cell Lung Cancer Non-Squamous With Mutated EGFR Compared With Chemoradiotherapy In Wild Type
  oleh: Wiendo Syah Putra Yahya
  Terbitan: (2014)
• In-silico screening of inhibitor on protein epidermal growth factor receptor (EGFR)
  oleh: Ongko, Jeremi, et al.
  Terbitan: (2022)
• Epidermal Growth Factor Receptor (EGFR) as a New Target in Cancer Therapy
  oleh: Santosa, Wahyu Budi; Dokter Umum di Jakarta
  Terbitan: (2012)